Health: Why Some Statins Work Better
A trial of the cholesterol-lowering statin drug Lipitor last March found that high doses lowered patients' levels of LDL (the "bad" cholesterol) and also reduced their heart-attack risk. That's why the results of a new study on similarly high doses of the statin Zocor are so disappointing. In the 4,500patient study, published online by the Journal of the American Medical Association, patients taking high doses of Zocor fared no better than a low-dose group in terms of heart-attack risk, despite low LDL levels. Why? Perhaps because Lipitor works not just by lowering cholesterol but also by reducing inflammation, something Zocor can't do as well.
Most Popular »
- Why Brittany Murphy Is Worth Remembering
- Israel vs. Hizballah: Drumbeats of War
- No Churchgoing Christmas for the First Family
- The Pentagon Prepares for a Missile Attack from 'Iran'
- Lindsey Graham: New GOP Maverick in the Senate
- Will Bad Blood Scuttle the Pacquiao-Mayweather Fight?
- Should the U.S. Destroy Jihadist Websites?
- In Germany, a Disturbing Rise of Right-Wing Violence
- Sean Goldman: Home by Christmas?
- How Panera Bread Defies the Recession
- How Panera Bread Defies the Recession
- Why Brittany Murphy Is Worth Remembering
- Hong Kong: 10 Things to Do in 24 Hours
- Michael Schumacher: F1 Star to Return
- The Job Market: Is a College Degree Worth Less?
- Obama Shrinks the War on Terrorism
- Lindsey Graham: New GOP Maverick in the Senate
- Balloon Boy Dad Gets 90 Days in Jail
- Domestic Terror Incidents Hit a Peak in 2009
- Tapping Into India's Growing Alcohol Market
RSS